Evidence map›Paper›PMID 34453034›Full record

ArticleTranslational psychiatry2021

Cerebral μ-opioid and CB

Tatu Kantonen, Tomi Karjalainen, Laura Pekkarinen, Janne Isojärvi, Kari Kalliokoski, Valtteri Kaasinen, Jussi Hirvonen, Pirjo Nuutila, Lauri Nummenmaa

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Cannabinoid Receptor Type 1 in Parkinson's Disease: A Positron Emission Tomography Study with [Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Tatu KantonenTurku PET Centre, University of Turku, Turku, Finland. taskan@utu.fi.ORCID 0000-0002-2336-0426
Tomi KarjalainenTurku PET Centre, University of Turku, Turku, Finland.
Laura PekkarinenTurku PET Centre, University of Turku, Turku, Finland.ORCID 0000-0002-5596-0485
Janne IsojärviTurku PET Centre, University of Turku, Turku, Finland.
Kari KalliokoskiTurku PET Centre, University of Turku, Turku, Finland.
Valtteri KaasinenClinical Neurosciences, University of Turku, Turku, Finland.ORCID 0000-0002-3446-7093
Jussi HirvonenTurku PET Centre, University of Turku, Turku, Finland.ORCID 0000-0002-0368-3746
Pirjo NuutilaTurku PET Centre, University of Turku, Turku, Finland.ORCID 0000-0001-9597-338X
Lauri NummenmaaTurku PET Centre, University of Turku, Turku, Finland.ORCID 0000-0002-2497-9757
University of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eating behavior varies greatly between individuals, but the neurobiological basis of these trait-like differences in feeding remains poorly understood. Central μ-opioid receptors (MOR) and cannabinoid CB

Indexed as

Analgesics, OpioidReceptors, Opioid, muFeeding BehaviorFemaleHumansMalePositron-Emission TomographyReceptor, Cannabinoid, CB1Retrospective StudiesAnalgesics, OpioidReceptor, Cannabinoid, CB1Receptors, Opioid, mu

Identifiers

PMID34453034
PMCPMC8397789
OpenAlexW3193943478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.